Abbott said that it has signed a definitive deal to acquire Alere for a net value of $5.8 billion in cash. Abbott expects the acquisition to be immediately accretive to its earnings per share upon completion.
point-of-care diagnostic tests
Breaking News
Nanomix Inc, a California-based nanotechnology firm that develops next generation point-of-care diagnostic tests, received $12 million in private funding from "a strategic corporate partner and existing investors."
